High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with (18)F-DCFPyL

OBJECTIVES: In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RLT must have certainty on the repeatability of PSMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Rudolf A., Habacha, Bilêl, Lütje, Susanne, Bundschuh, Lena, Higuchi, Takahiro, Hartrampf, Philipp, Serfling, Sebastian E., Derlin, Thorsten, Lapa, Constantin, Buck, Andreas K., Essler, Markus, Pienta, Kenneth J., Eisenberger, Mario A., Markowski, Mark C., Shinehouse, Laura, AbdAllah, Rehab, Salavati, Ali, Lodge, Martin A., Pomper, Martin G., Gorin, Michael A., Bundschuh, Ralph A., Rowe, Steven P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896803/
https://www.ncbi.nlm.nih.gov/pubmed/35283693
http://dx.doi.org/10.1155/2022/7056983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896803/
https://www.ncbi.nlm.nih.gov/pubmed/35283693
http://dx.doi.org/10.1155/2022/7056983

Ejemplares similares